| Literature DB >> 18760004 |
Hannah C Lewis1, Kåre Mølbak, Catrin Reese, Frank M Aarestrup, Mette Selchau, Marit Sørum, Robert L Skov.
Abstract
An emerging subtype of methicillin-resistant Staphylococcus aureus (MRSA), clonal complex (CC) 398, is associated with animals, particularly pigs. We conducted a matched case-control and a case-case study comparing 21 CC398 case-patients with 2 controls randomly selected from the Danish Civil Registry and 2 case-patients infected with MRSA other than CC398. On farms of case-patients, animals were examined for MRSA. Thirteen case-patients reported pig exposure. Living or working on farms with animals was an independent risk factor for CC398 in the case-control (matched odds ratio [MOR] 35.4, 95% confidence interval [CI] 2.7-469.8) and the case-case study (MOR 14.5, 95%CI 2.7-76.7). History of hospitalization was associated with an increased risk only in the case-control study (MOR 11.4, 95% CI 1.4-94.8). A total of 23 of 50 pigs on 4 of 5 farms were positive for CC398. Our results, corroborated by microbiologic testing, demonstrate that pigs are a source of CC398 in Denmark.Entities:
Mesh:
Year: 2008 PMID: 18760004 PMCID: PMC2603104 DOI: 10.3201/eid1409.071576
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Statistically significant associations by univariable analysis for infection with MRSA CC398, Denmark*
| Exposure variable | No. (%) case-patients exposed (n = 21) | Odds ratio (95% confidence interval) for MRSA infection | ||
|---|---|---|---|---|
| Case–control study, population controls (n = 42) | Case–case study, non-CC398 case-patients (n = 39) | |||
| Animal and farm-related exposures | ||||
| Lived or worked on farm with animals | 14 (67) | 22.1 (2.9–170.3) | 11.6 (2.6–51.7) | |
| Worked with animals or meat | 11 (50) | 16.2 (2.0–127.8) | ∞† | |
| Worked on farm with animals | 10 (48) | ∞† | ∞† | |
| Lived on farm with animals | 9 (43) | 6.9 (1.5–32.8) | 7.9 (1.7–36.7) | |
| Exposure to pigs | 13 (62) | ∞† | ∞† | |
| Exposure to cattle | 6 (29) | ∞† | ∞† | |
| Exposure to other farm animals (hens, goats, sh eep) | 7 (33) | 11.1 (1.4–92.4) | 5.9 (1.2–28.8) | |
| Provided antimicrobial drugs to animals | 10 (48) | ∞† | ∞† | |
| Contact with farm workers | 16 (76) | 5.2 (1.4–19.3) | ∞† | |
| Contact with farmer | 14 (67) | 3.2 (1.0–10.6) | ∞† | |
| Contact with veterinarian | 7 (33) | 6.3 (1.3–30.7) | 6.6 (1.4–31.8) | |
| Lived in countryside | 13 (62) | 7.2 (1.5–33.8) | 5.2 (1.4–18.9) | |
| Had cat in home | 11 (50) | 3.2 (1.0–10.6) | 3.4 (1.1–9.9) | |
| Used manure in garden | 7 (33) | 3.2 (0.9–11.0) | 6.6 (1.4–31.8) | |
| Visited farm, zoo, or stables | 12 (57) |
| 0.8 (0.3–2.4) | 4.7 (1.3–17.4) |
| Medical-related exposures | ||||
| Admission to hospital in 12 mo before diagnosis | 13 (62) | 6.8 (1.9–24.4) | 1.5 (0.4–5.2) | |
| Someone in household with chronic condition | 12 (57) | 3.8 (1.2–12.5) | 2.0 (0.8–9.3) | |
| Antimicrobial drug use in 12 mo before diagnosis | 9 (43) | 3.4 (1.0–11.5) | 2.6 (0.8–9.2) | |
| Contact with person with skin sore or other skin infection | 5 (26) | 8.6 (1–74.9) | 0.6 (0.2–1.9) | |
*MRSA, methicillin-resistant Staphylococcus aureus; CC, clonal complex. †p<0.01, by unmatched analysis.
Isolate characteristics for human case-patients and contact pig herds sampled, Denmark, March 2007*
| Case-patient no. | Date of diagnosis | Resistance pattern | Contact herd | No. isolates | Resistance pattern | ||
|---|---|---|---|---|---|---|---|
| 1 | 2005 Mar | tet, ery, cli, str, tmp | t034 | A | 9 | tet, ery, cli, str, spe, tmp | t034 |
| 2 | 2005 Oct | tet, tmp | t034 | B | 5 | tet, tmp | t034 |
| 4 | tet, str, tmp | t034 | |||||
|
|
|
|
|
| 1 | tet, str, tmp | t038 |
| 3 | 2006 Oct | tet, ery, cli, str, spe, tmp | t034 | C | 1 | tet, ery, cli,str, spe, tmp | t034 |
|
|
|
|
|
| 2 | tet, str, spe, tmp | t034 |
| 4 | 2006 Nov | tet, kan, str, spe, tmp | t034 | D | 1 | tet, ery, cli, kan, str, spe, tmp | t034 |
*spa, staphylococcal protein A; tet, tetracycline; ery, erythromycin; cli, clindamycin; str, streptomycin; tmp, trimethoprim; spe, spectinomycin; kan, kananmycin.